{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:20:43Z","timestamp":1793910043748,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014807","name":"Cancer Research Coordinating Committee","doi-asserted-by":"publisher","award":["C21CR2125"],"award-info":[{"award-number":["C21CR2125"]}],"id":[{"id":"10.13039\/100014807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA23100"],"award-info":[{"award-number":["P30CA23100"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008167","name":"Pancreatic Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MRC0227"],"award-info":[{"award-number":["MRC0227"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jpet.2025.103573","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T18:21:13Z","timestamp":1743963673000},"page":"103573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2259-3807","authenticated-orcid":false,"given":"Cristina","family":"Salmer\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7897-8891","authenticated-orcid":false,"given":"Elena","family":"Tom\u00e1s Bort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0209-3311","authenticated-orcid":false,"given":"Mehrak","family":"Javadi-Paydar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Smitham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Grose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5575-9968","authenticated-orcid":false,"given":"Anna","family":"DiNardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Tiriac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7106-0735","authenticated-orcid":false,"given":"Andrew M.","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Insel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103573_bib1","article-title":"Pancreatic ductal adenocarcinoma, \u03b2-blockers, and antihistamines: a clinical trial is needed","volume":"6","author":"Baker","year":"2025","journal-title":"Function (Oxf)"},{"key":"10.1016\/j.jpet.2025.103573_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103573_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2025.103573_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9524075","article-title":"Role of histamine in modulating the immune response and inflammation","volume":"2018","author":"Branco","year":"2018","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jpet.2025.103573_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/sj.bjc.6605450","article-title":"Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene","volume":"102","author":"Buffa","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jpet.2025.103573_bib6","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1158\/1078-0432.CCR-11-0607","article-title":"Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma","volume":"17","author":"Chang","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpet.2025.103573_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jpet.2025.103573_bib8","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.e16253","article-title":"The efficacy of cationic amphiphilic antihistamines on outcomes of patients with pancreatic ductal adenocarcinoma","volume":"41","author":"Chiang","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpet.2025.103573_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.833832","article-title":"PDE4B is a homeostatic regulator of cyclic AMP in dendritic cells","volume":"13","author":"Chinn","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2025.103573_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jpet.2025.103573_bib11","series-title":"Fexofenadine","author":"Craun","year":"2024"},{"key":"10.1016\/j.jpet.2025.103573_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1157397","article-title":"Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma","volume":"14","author":"Daunke","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2025.103573_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/CAD.0000000000001498","article-title":"Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients","volume":"35","author":"Eylemer Mocan","year":"2024","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jpet.2025.103573_bib14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1158\/2159-8290.CD-20-0633","article-title":"Cell of origin influences pancreatic cancer subtype","volume":"11","author":"Flowers","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jpet.2025.103573_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101029","article-title":"Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine","volume":"14","author":"Fritz","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jpet.2025.103573_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/acssensors.2c01341","article-title":"GPCR signaling measurement and drug profiling with an automated live-cell microscopy system","volume":"8","author":"Greenwald","year":"2023","journal-title":"ACS Sens"},{"key":"10.1016\/j.jpet.2025.103573_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1258538","article-title":"An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer","volume":"14","author":"Guo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2025.103573_bib18","doi-asserted-by":"crossref","first-page":"D1438","DOI":"10.1093\/nar\/gkad944","article-title":"The IUPHAR\/BPS guide to pharmacology in 2024","volume":"52","author":"Harding","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpet.2025.103573_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s43018-022-00349-2","article-title":"Translational advances in pancreatic ductal adenocarcinoma therapy","volume":"3","author":"Hosein","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jpet.2025.103573_bib20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/ijc.31241","article-title":"Atopic allergic conditions and pancreatic cancer risk: results from the Multiethnic Cohort Study","volume":"142","author":"Huang","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jpet.2025.103573_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fphar.2018.00431","article-title":"GPCRomics: GPCR expression in cancer cells and tumors identifies new, potential biomarkers and therapeutic targets","volume":"9","author":"Insel","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2025.103573_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccell.2021.11.002","article-title":"The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jpet.2025.103573_bib23","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2019-215543","article-title":"Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis","volume":"78","author":"Liu","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jpet.2025.103573_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jpet.2025.103573_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10238-018-0493-6","article-title":"Mast cells and angiogenesis in pancreatic ductal adenocarcinoma","volume":"18","author":"Longo","year":"2018","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jpet.2025.103573_bib26","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202001064","article-title":"SuperPlots: communicating reproducibility and variability in cell biology","volume":"219","author":"Lord","year":"2020","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jpet.2025.103573_bib27","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1158\/0008-5472.CAN-12-4479","article-title":"Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer","volume":"73","author":"Ma","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpet.2025.103573_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188387","article-title":"Local and systemic immunosuppression in pancreatic cancer: targeting the stalwarts in tumor\u2019s arsenal","volume":"1874","author":"Mundry","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jpet.2025.103573_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110227","article-title":"Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion","volume":"38","author":"Murray","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jpet.2025.103573_bib30","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/biom11081232","article-title":"Pathophysiological roles of histamine receptors in cancer progression: implications and perspectives as potential molecular targets","volume":"11","author":"Nguyen","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpet.2025.103573_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative proteomics of the cancer cell line encyclopedia","volume":"180","author":"Nusinow","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2025.103573_bib32","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41598-023-28531-1","article-title":"Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration","volume":"13","author":"Park","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103573_bib33","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1038\/s41467-019-12517-7","article-title":"De novo compartment deconvolution and weight estimation of tumor samples using DECODER","volume":"10","author":"Peng","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpet.2025.103573_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41568-024-00679-6","article-title":"Combinatorial strategies to target RAS-driven cancers","volume":"24","author":"Perurena","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jpet.2025.103573_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/bjc.2014.604","article-title":"The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer","volume":"112","author":"Ragnum","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jpet.2025.103573_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102165","article-title":"Chronic ingestion of H1-antihistamines increase progression of atherosclerosis in apolipoprotein E-\/- mice","volume":"9","author":"Raveendran","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2025.103573_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1360629","article-title":"High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment","volume":"15","author":"Sadozai","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2025.103573_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2020.07.041","article-title":"Hypoxia: friend or foe for drug delivery in pancreatic cancer","volume":"492","author":"Shah","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jpet.2025.103573_bib39","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jpet.2025.103573_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1408312","article-title":"Unveiling the role of interleukin-6 in pancreatic cancer occurrence and progression","volume":"15","author":"Song","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jpet.2025.103573_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.117.111062","article-title":"G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs?","volume":"93","author":"Sriram","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jpet.2025.103573_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000434","article-title":"GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors","volume":"17","author":"Sriram","year":"2019","journal-title":"PLOS Biol"},{"key":"10.1016\/j.jpet.2025.103573_bib43","doi-asserted-by":"crossref","first-page":"17048","DOI":"10.1021\/acsomega.9b02811","article-title":"Detection and quantification of GPCR mRNA: an assessment and implications of data from high-content methods","volume":"4","author":"Sriram","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpet.2025.103573_bib44","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-09-1230","article-title":"Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression","volume":"16","author":"Strouch","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpet.2025.103573_bib45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.tibtech.2018.12.002","article-title":"The ultimate qPCR experiment: producing publication quality, reproducible data the first time","volume":"37","author":"Taylor","year":"2019","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jpet.2025.103573_bib46","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jpet.2025.103573_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86971","article-title":"Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion","volume":"12","author":"Tom\u00e1s Bort","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jpet.2025.103573_bib48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2025.103573_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jpet.2025.103573_bib50","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1096\/fj.201700834R","article-title":"GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells","volume":"32","author":"Wiley","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.jpet.2025.103573_bib51","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-06-3322","article-title":"Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers","volume":"67","author":"Winter","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpet.2025.103573_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13046-024-03060-5","article-title":"Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells","volume":"43","author":"Zhong","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jpet.2025.103573_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790661","article-title":"Prognostic stratification based on HIF-1 signaling for evaluating hypoxic status and immune infiltration in pancreatic ductal adenocarcinomas","volume":"12","author":"Zhuang","year":"2021","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.1016\/j.jpet.2026.104305","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525397867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525397867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:17:12Z","timestamp":1776169032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525397867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0022356525397867"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103573","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"103573"}}